 | • レポートコード：QYR2104Z1623 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、155ページ • 納品方法：Eメール（納期：3日） • 産業分類：New Technology |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、新型コロナウイルス感染症分子診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ハイスループットシーケンシング、リアルタイム蛍光定量PCRベース核酸検出、免疫学的検出）、用途別市場規模（病院、科学研究、生物診断）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・新型コロナウイルス感染症分子診断の市場動向 ・企業の競争状況、市場シェア ・新型コロナウイルス感染症分子診断の種類別市場規模（ハイスループットシーケンシング、リアルタイム蛍光定量PCRベース核酸検出、免疫学的検出） ・新型コロナウイルス感染症分子診断の用途別市場規模（病院、科学研究、生物診断） ・新型コロナウイルス感染症分子診断の北米市場規模2016-2027（アメリカ、カナダ） ・新型コロナウイルス感染症分子診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・新型コロナウイルス感染症分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・新型コロナウイルス感染症分子診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・新型コロナウイルス感染症分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Cellex、Abbott、Roche、BioMedomics、BD、Henry Schein、Safecare Bio-Tech、Thermo Fisher、Bio-rad、Agilent、Ortho Clinical Diagnostics、Zhejiang Orient Gene Biotech、Innovita Biological Technology、Guangzhou Wondfo Biotech、Guangdong Hecin-Scientific、Dynamiker Biotechnology (Tianjin)、ADVAITE、Mayo Clinic Laboratories、Chembio Diagnostics、Mount Sinai Laboratory、QIAGEN、Bioer、Biosynex、Esco、Analytik Jena、Techne、Da An Gene、BGI、Shanghai ZJ Bio-Tech） ・結論 |
COVID-19 has seen the molecular in vitro diagnostics (IVD) industry bring out its best efforts in terms of fast test RT-PCR tests for their systems, point of care solutions, syndromic tests, high throughput systems and surge production on badly needed kits.
In 2021, the global COVID-19 Molecular Diagnostics market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global COVID-19 Molecular Diagnostics status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the COVID-19 Molecular Diagnostics development in North America, Europe, Japan, China, Southeast Asia, India, etc.
Global COVID-19 Molecular Diagnostics Scope and Market Size
COVID-19 Molecular Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global COVID-19 Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
High-throughput Sequencing
Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
Immunological Detection
Segment by Application
Hospitals
Scientific Research
Biodiagnostics
By Region
North America
Europe
Japan
China
Southeast Asia
India
By Company
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Thermo Fisher
Bio-rad
Agilent
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
QIAGEN
Bioer
Biosynex
Esco
Analytik Jena
Techne
Da An Gene
BGI
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Molecular Diagnostics Market Size Growth Rate by Type (2021-2027)
1.2.2 High-throughput Sequencing
1.2.3 Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
1.2.4 Immunological Detection
1.3 Market by Application
1.3.1 Global COVID-19 Molecular Diagnostics Market Share by Application (2021-2027)
1.3.2 Hospitals
1.3.3 Scientific Research
1.3.4 Biodiagnostics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global COVID-19 Molecular Diagnostics Market Size
2.2 COVID-19 Molecular Diagnostics Market Size by Regions
2.2.1 COVID-19 Molecular Diagnostics Growth Rate by Regions (2021-2027)
2.2.2 COVID-19 Molecular Diagnostics Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 COVID-19 Molecular Diagnostics Revenue by Players (2020-2021)
3.2 COVID-19 Molecular Diagnostics Key Players Headquaters and Area Served
3.3 Key Players COVID-19 Molecular Diagnostics Product/Solution/Service
3.4 Date of Enter into COVID-19 Molecular Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global COVID-19 Molecular Diagnostics Market Size by Type (2021-2027)
4.2 Global COVID-19 Molecular Diagnostics Market Size by Application (2021-2027)
5 North America
5.1 North America COVID-19 Molecular Diagnostics Market Forecast (2021-2027)
5.2 COVID-19 Molecular Diagnostics Key Players in North America
5.3 North America COVID-19 Molecular Diagnostics Market Size by Type
5.4 North America COVID-19 Molecular Diagnostics Market Size by Application
6 Europe
6.1 Europe COVID-19 Molecular Diagnostics Market Forecast (2021-2027)
6.2 COVID-19 Molecular Diagnostics Key Players in Europe
6.3 Europe COVID-19 Molecular Diagnostics Market Size by Type
6.4 Europe COVID-19 Molecular Diagnostics Market Size by Application
7 Japan
7.1 Japan COVID-19 Molecular Diagnostics Market Forecast (2021-2027)
7.2 COVID-19 Molecular Diagnostics Key Players in Europe
7.3 Japan COVID-19 Molecular Diagnostics Market Size by Type
7.4 Japan COVID-19 Molecular Diagnostics Market Size by Application
8 Rest of World
8.1 China
8.1.1 China COVID-19 Molecular Diagnostics Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia COVID-19 Molecular Diagnostics Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India COVID-19 Molecular Diagnostics Market Analysis
8.3.2 Key Players in India
9 International Player Profiles
9.1 Cellex
9.1.1 Cellex Company Details
9.1.2 Cellex Description and Business Overview
9.1.3 Cellex COVID-19 Molecular Diagnostics Introduction
9.1.4 Cellex Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.1.5 Cellex Recent Development
9.2 Abbott
9.2.1 Abbott Company Details
9.2.2 Abbott Description and Business Overview
9.2.3 Abbott COVID-19 Molecular Diagnostics Introduction
9.2.4 Abbott Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.2.5 Abbott Recent Development
9.3 Roche
9.3.1 Roche Company Details
9.3.2 Roche Description and Business Overview
9.3.3 Roche COVID-19 Molecular Diagnostics Introduction
9.3.4 Roche Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.3.5 Roche Recent Development
9.4 BioMedomics
9.4.1 BioMedomics Company Details
9.4.2 BioMedomics Description and Business Overview
9.4.3 BioMedomics COVID-19 Molecular Diagnostics Introduction
9.4.4 BioMedomics Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.4.5 BioMedomics Recent Development
9.5 BD
9.5.1 BD Company Details
9.5.2 BD Description and Business Overview
9.5.3 BD COVID-19 Molecular Diagnostics Introduction
9.5.4 BD Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.5.5 BD Recent Development
9.6 Henry Schein
9.6.1 Henry Schein Company Details
9.6.2 Henry Schein Description and Business Overview
9.6.3 Henry Schein COVID-19 Molecular Diagnostics Introduction
9.6.4 Henry Schein Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.6.5 Henry Schein Recent Development
9.7 Safecare Bio-Tech
9.7.1 Safecare Bio-Tech Company Details
9.7.2 Safecare Bio-Tech Description and Business Overview
9.7.3 Safecare Bio-Tech COVID-19 Molecular Diagnostics Introduction
9.7.4 Safecare Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.7.5 Safecare Bio-Tech Recent Development
9.8 Thermo Fisher
9.8.1 Thermo Fisher Company Details
9.8.2 Thermo Fisher Description and Business Overview
9.8.3 Thermo Fisher COVID-19 Molecular Diagnostics Introduction
9.8.4 Thermo Fisher Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.8.5 Thermo Fisher Recent Development
9.9 Bio-rad
9.9.1 Bio-rad Company Details
9.9.2 Bio-rad Description and Business Overview
9.9.3 Bio-rad COVID-19 Molecular Diagnostics Introduction
9.9.4 Bio-rad Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.9.5 Bio-rad Recent Development
9.10 Agilent
9.10.1 Agilent Company Details
9.10.2 Agilent Description and Business Overview
9.10.3 Agilent COVID-19 Molecular Diagnostics Introduction
9.10.4 Agilent Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.10.5 Agilent Recent Development
9.11 Ortho Clinical Diagnostics
9.11.1 Ortho Clinical Diagnostics Company Details
9.11.2 Ortho Clinical Diagnostics Description and Business Overview
9.11.3 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Introduction
9.11.4 Ortho Clinical Diagnostics Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.11.5 Ortho Clinical Diagnostics Recent Development
9.12 Zhejiang Orient Gene Biotech
9.12.1 Zhejiang Orient Gene Biotech Company Details
9.12.2 Zhejiang Orient Gene Biotech Description and Business Overview
9.12.3 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Introduction
9.12.4 Zhejiang Orient Gene Biotech Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.12.5 Zhejiang Orient Gene Biotech Recent Development
9.13 Innovita Biological Technology
9.13.1 Innovita Biological Technology Company Details
9.13.2 Innovita Biological Technology Description and Business Overview
9.13.3 Innovita Biological Technology COVID-19 Molecular Diagnostics Introduction
9.13.4 Innovita Biological Technology Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.13.5 Innovita Biological Technology Recent Development
9.14 Guangzhou Wondfo Biotech
9.14.1 Guangzhou Wondfo Biotech Company Details
9.14.2 Guangzhou Wondfo Biotech Description and Business Overview
9.14.3 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Introduction
9.14.4 Guangzhou Wondfo Biotech Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.14.5 Guangzhou Wondfo Biotech Recent Development
9.15 Guangdong Hecin-Scientific
9.15.1 Guangdong Hecin-Scientific Company Details
9.15.2 Guangdong Hecin-Scientific Description and Business Overview
9.15.3 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Introduction
9.15.4 Guangdong Hecin-Scientific Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.15.5 Guangdong Hecin-Scientific Recent Development
9.16 Dynamiker Biotechnology (Tianjin)
9.16.1 Company Details
9.16.2 Dynamiker Biotechnology (Tianjin) Description and Business Overview
9.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Introduction
9.16.4 Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.16.5 Dynamiker Biotechnology (Tianjin) Recent Development
9.17 ADVAITE
9.17.1 ADVAITE Company Details
9.17.2 ADVAITE Description and Business Overview
9.17.3 ADVAITE COVID-19 Molecular Diagnostics Introduction
9.17.4 ADVAITE Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.17.5 ADVAITE Recent Development
9.18 Mayo Clinic Laboratories
9.18.1 Mayo Clinic Laboratories Company Details
9.18.2 Mayo Clinic Laboratories Description and Business Overview
9.18.3 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Introduction
9.18.4 Mayo Clinic Laboratories Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.18.5 Mayo Clinic Laboratories Recent Development
9.18 Chembio Diagnostics
9.25.1 Chembio Diagnostics Company Details
9.25.2 Chembio Diagnostics Description and Business Overview
9.25.3 Chembio Diagnostics COVID-19 Molecular Diagnostics Introduction
9.25.4 Chembio Diagnostics Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.25.5 Chembio Diagnostics Recent Development
9.20 Mount Sinai Laboratory
9.20.1 Mount Sinai Laboratory Company Details
9.20.2 Mount Sinai Laboratory Description and Business Overview
9.20.3 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Introduction
9.20.4 Mount Sinai Laboratory Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.20.5 Mount Sinai Laboratory Recent Development
9.21 QIAGEN
9.21.1 QIAGEN Company Details
9.21.2 QIAGEN Description and Business Overview
9.21.3 QIAGEN COVID-19 Molecular Diagnostics Introduction
9.21.4 QIAGEN Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.21.5 QIAGEN Recent Development
9.22 Bioer
9.22.1 Bioer Company Details
9.22.2 Bioer Description and Business Overview
9.22.3 Bioer COVID-19 Molecular Diagnostics Introduction
9.22.4 Bioer Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.22.5 Bioer Recent Development
9.23 Biosynex
9.23.1 Biosynex Company Details
9.23.2 Biosynex Description and Business Overview
9.23.3 Biosynex COVID-19 Molecular Diagnostics Introduction
9.23.4 Biosynex Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.23.5 Biosynex Recent Development
9.24 Esco
9.24.1 Esco Company Details
9.24.2 Esco Description and Business Overview
9.24.3 Esco COVID-19 Molecular Diagnostics Introduction
9.24.4 Esco Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.24.5 Esco Recent Development
9.25 Analytik Jena
9.25.1 Analytik Jena Company Details
9.25.2 Analytik Jena Description and Business Overview
9.25.3 Analytik Jena COVID-19 Molecular Diagnostics Introduction
9.25.4 Analytik Jena Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.25.5 Analytik Jena Recent Development
9.26 Techne
9.26.1 Techne Company Details
9.26.2 Techne Description and Business Overview
9.26.3 Techne COVID-19 Molecular Diagnostics Introduction
9.26.4 Techne Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.26.5 Techne Recent Development
9.27 Da An Gene
9.27.1 Da An Gene Company Details
9.27.2 Da An Gene Description and Business Overview
9.27.3 Da An Gene COVID-19 Molecular Diagnostics Introduction
9.27.4 Da An Gene Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.27.5 Da An Gene Recent Development
9.28 BGI
9.28.1 BGI Company Details
9.28.2 BGI Description and Business Overview
9.28.3 BGI COVID-19 Molecular Diagnostics Introduction
9.28.4 BGI Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.28.5 BGI Recent Development
9.29 Shanghai ZJ Bio-Tech
9.29.1 Shanghai ZJ Bio-Tech Company Details
9.29.2 Shanghai ZJ Bio-Tech Description and Business Overview
9.29.3 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Introduction
9.29.4 Shanghai ZJ Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business (2020-2021)
9.29.5 Shanghai ZJ Bio-Tech Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
Table 1. Global COVID-19 Molecular Diagnostics Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of High-throughput Sequencing
Table 3. Key Players of Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
Table 4. Key Players of Immunological Detection
Table 5. Global COVID-19 Molecular Diagnostics Market Size Growth by Application (2021-2027) (US$ Million)
Table 6. Global COVID-19 Molecular Diagnostics Market Size by Regions (2021-2027) (US$ Million)
Table 7. Global COVID-19 Molecular Diagnostics Market Share by Regions (2021-2027)
Table 8. Market Top Trends
Table 9. Market Use Cases
Table 10. Global COVID-19 Molecular Diagnostics Revenue by Players (2020-2021) (US$ Million)
Table 11. Global COVID-19 Molecular Diagnostics Market Share by Players (2020-2021)
Table 12. Key Players Headquarters and Area Served
Table 13. Key Players COVID-19 Molecular Diagnostics Product Solution and Service
Table 14. Date of Enter into COVID-19 Molecular Diagnostics Market
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global COVID-19 Molecular Diagnostics Market Size by Type (2021-2027) (US$ Million)
Table 17. Global COVID-19 Molecular Diagnostics Market Size Share by Type (2021-2027)
Table 18. Global COVID-19 Molecular Diagnostics Market Size by Application (2021-2027) (US$ Million)
Table 19. Global COVID-19 Molecular Diagnostics Market Size Share by Application (2021-2027)
Table 20. North America Key Players COVID-19 Molecular Diagnostics Revenue (2020-2021) (US$ Million)
Table 21. North America Key Players COVID-19 Molecular Diagnostics Market Share (2020-2021)
Table 22. North America COVID-19 Molecular Diagnostics Market Size by Type (2021-2027) (US$ Million)
Table 23. North America COVID-19 Molecular Diagnostics Market Share by Type (2021-2027)
Table 24. North America COVID-19 Molecular Diagnostics Market Size by Application (2021-2027) (US$ Million)
Table 25. North America COVID-19 Molecular Diagnostics Market Share by Application (2021-2027)
Table 26. Europe Key Players COVID-19 Molecular Diagnostics Revenue (2020-2021) (US$ Million)
Table 27. Europe Key Players COVID-19 Molecular Diagnostics Market Share (2020-2021)
Table 28. Europe COVID-19 Molecular Diagnostics Market Size by Type (2021-2027) (US$ Million)
Table 29. Europe COVID-19 Molecular Diagnostics Market Share by Type (2021-2027)
Table 30. Europe COVID-19 Molecular Diagnostics Market Size by Application (2021-2027) (US$ Million)
Table 31. Europe COVID-19 Molecular Diagnostics Market Share by Application (2021-2027)
Table 32. Japan Key Players COVID-19 Molecular Diagnostics Revenue (2020-2021) (US$ Million)
Table 33. Japan Key Players COVID-19 Molecular Diagnostics Market Share (2020-2021)
Table 34. Japan COVID-19 Molecular Diagnostics Market Size by Type (2021-2027) (US$ Million)
Table 35. Japan COVID-19 Molecular Diagnostics Market Share by Type (2021-2027)
Table 36. Japan COVID-19 Molecular Diagnostics Market Size by Application (2021-2027) (US$ Million)
Table 37. Japan COVID-19 Molecular Diagnostics Market Share by Application (2021-2027)
Table 38. Key Players in China
Table 39. Key Players in Southeast Asia
Table 40. Key Players in India
Table 41. Cellex Company Details
Table 42. Cellex Description and Business Overview
Table 43. Cellex COVID-19 Molecular Diagnostics Product
Table 44. Cellex Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 45. Cellex Recent Development
Table 46. Abbott Company Details
Table 47. Abbott Description and Business Overview
Table 48. Abbott COVID-19 Molecular Diagnostics Product
Table 49. Abbott Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 50. Abbott Recent Development
Table 51. Roche Company Details
Table 52. Roche Description and Business Overview
Table 53. Roche COVID-19 Molecular Diagnostics Product
Table 54. Roche Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 55. Roche Recent Development
Table 56. BioMedomics Company Details
Table 57. BioMedomics Description and Business Overview
Table 58. BioMedomics COVID-19 Molecular Diagnostics Product
Table 59. BioMedomics Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 60. BioMedomics Recent Development
Table 61. BD Company Details
Table 62. BD Description and Business Overview
Table 63. BD COVID-19 Molecular Diagnostics Product
Table 64. BD Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 65. BD Recent Development
Table 66. Henry Schein Company Details
Table 67. Henry Schein Description and Business Overview
Table 68. Henry Schein COVID-19 Molecular Diagnostics Product
Table 69. Henry Schein Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 70. Henry Schein Recent Development
Table 71. Safecare Bio-Tech Company Details
Table 72. Safecare Bio-Tech Description and Business Overview
Table 73. Safecare Bio-Tech COVID-19 Molecular Diagnostics Product
Table 74. Safecare Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 75. Safecare Bio-Tech Recent Development
Table 76. Thermo Fisher Company Details
Table 77. Thermo Fisher Description and Business Overview
Table 78. Thermo Fisher COVID-19 Molecular Diagnostics Product
Table 79. Thermo Fisher Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 80. Thermo Fisher Recent Development
Table 81. Bio-rad Company Details
Table 82. Bio-rad Description and Business Overview
Table 83. Bio-rad COVID-19 Molecular Diagnostics Product
Table 84. Bio-rad Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 85. Bio-rad Recent Development
Table 86. Agilent Company Details
Table 87. Agilent Description and Business Overview
Table 88. Agilent COVID-19 Molecular Diagnostics Product
Table 89. Agilent Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 90. Agilent Recent Development
Table 91. Ortho Clinical Diagnostics Company Details
Table 92. Ortho Clinical Diagnostics Description and Business Overview
Table 93. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Product
Table 94. Ortho Clinical Diagnostics Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 95. Ortho Clinical Diagnostics Recent Development
Table 96. Zhejiang Orient Gene Biotech Company Details
Table 97. Zhejiang Orient Gene Biotech Description and Business Overview
Table 98. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Product
Table 99. Zhejiang Orient Gene Biotech Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 100. Zhejiang Orient Gene Biotech Recent Development
Table 101. Innovita Biological Technology Company Details
Table 102. Innovita Biological Technology Description and Business Overview
Table 103. Innovita Biological Technology COVID-19 Molecular Diagnostics Product
Table 104. Innovita Biological Technology Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 105. Innovita Biological Technology Recent Development
Table 106. Guangzhou Wondfo Biotech Company Details
Table 107. Guangzhou Wondfo Biotech Description and Business Overview
Table 108. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Product
Table 109. Guangzhou Wondfo Biotech Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 110. Guangzhou Wondfo Biotech Recent Development
Table 111. Guangdong Hecin-Scientific Company Details
Table 112. Guangdong Hecin-Scientific Description and Business Overview
Table 113. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Product
Table 114. Guangdong Hecin-Scientific Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 115. Guangdong Hecin-Scientific Recent Development
Table 116. Dynamiker Biotechnology (Tianjin) Company Details
Table 117. Dynamiker Biotechnology (Tianjin) Description and Business Overview
Table 118. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Product
Table 119. Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 120. Dynamiker Biotechnology (Tianjin) Recent Development
Table 121. ADVAITE Company Details
Table 122. ADVAITE Description and Business Overview
Table 123. ADVAITE COVID-19 Molecular Diagnostics Product
Table 124. ADVAITE Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 125. ADVAITE Recent Development
Table 126. Mayo Clinic Laboratories Company Details
Table 127. Mayo Clinic Laboratories Description and Business Overview
Table 128. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Product
Table 129. Mayo Clinic Laboratories Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 130. Mayo Clinic Laboratories Recent Development
Table 131. Chembio Diagnostics Company Details
Table 132. Chembio Diagnostics Description and Business Overview
Table 133. Chembio Diagnostics COVID-19 Molecular Diagnostics Product
Table 134. Chembio Diagnostics Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 135. Chembio Diagnostics Recent Development
Table 136. Mount Sinai Laboratory Company Details
Table 137. Mount Sinai Laboratory Description and Business Overview
Table 138. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Product
Table 139. Mount Sinai Laboratory Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 140. Mount Sinai Laboratory Recent Development
Table 141. QIAGEN Company Details
Table 142. QIAGEN Description and Business Overview
Table 143. QIAGEN COVID-19 Molecular Diagnostics Product
Table 144. QIAGEN Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 145. QIAGEN Recent Development
Table 146. Bioer Company Details
Table 147. Bioer Description and Business Overview
Table 148. Bioer COVID-19 Molecular Diagnostics Product
Table 149. Bioer Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 150. Bioer Recent Development
Table 151. Biosynex Company Details
Table 152. Biosynex Description and Business Overview
Table 153. Biosynex COVID-19 Molecular Diagnostics Product
Table 154. Biosynex Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 155. Biosynex Recent Development
Table 156. Esco Company Details
Table 157. Esco Description and Business Overview
Table 158. Esco COVID-19 Molecular DiagnosticsProduct
Table 159. Esco Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 160. Esco Recent Development
Table 161. Analytik Jena Company Details
Table 162. Analytik Jena Description and Business Overview
Table 163. Analytik Jena COVID-19 Molecular Diagnostics Product
Table 164. Analytik Jena Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 165. Analytik Jena Recent Development
Table 166. Techne Company Details
Table 167. Techne Description and Business Overview
Table 168. Techne COVID-19 Molecular Diagnostics Product
Table 169. Techne Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 170. Techne Recent Development
Table 171. Da An Gene Company Details
Table 172. Da An Gene Description and Business Overview
Table 173. Da An Gene COVID-19 Molecular Diagnostics Product
Table 174. Da An Gene Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 175. Da An Gene Recent Development
Table 176. BGI Company Details
Table 177. BGI Description and Business Overview
Table 178. BGI COVID-19 Molecular Diagnostics Product
Table 179. BGI Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 180. BGI Recent Development
Table 181. Shanghai ZJ Bio-Tech Company Details
Table 182. Shanghai ZJ Bio-Tech Description and Business Overview
Table 183. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Product
Table 184. Shanghai ZJ Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business 2020 and 2021
Table 185. Shanghai ZJ Bio-Tech Recent Development
Table 186. COVID-19 Molecular Diagnostics Market Trends
Table 187. COVID-19 Molecular Diagnostics Market Drivers
Table 188. COVID-19 Molecular Diagnostics Market Challenges
Table 189. COVID-19 Molecular Diagnostics Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COVID-19 Molecular Diagnostics Market Share by Type in 2021 & 2027
Figure 2. High-throughput Sequencing Features
Figure 3. Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR Features
Figure 4. Immunological Detection Features
Figure 5. Global COVID-19 Molecular Diagnostics Market Share by Application in 2021 & 2027
Figure 6. Hospitals Case Studies
Figure 7. Scientific Research Case Studies
Figure 8. Biodiagnostics Case Studies
Figure 9. COVID-19 Molecular Diagnostics Report Years Considered
Figure 10. Global COVID-19 Molecular Diagnostics Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 11. Global COVID-19 Molecular Diagnostics Market Share by Regions (2020-2027)
Figure 12. Global COVID-19 Molecular Diagnostics Market Share by Players in 2021
Figure 13. Global COVID-19 Molecular Diagnostics Market Size Market Share by Type (2021-2027)
Figure 14. Global COVID-19 Molecular Diagnostics Market Size Market Share by Application (2021-2027)
Figure 15. Global COVID-19 Molecular Diagnostics Revenue Market Share by Application in 2021
Figure 16. North America COVID-19 Molecular Diagnostics Market Size 2021-2027 (US$ Million)
Figure 17. Europe COVID-19 Molecular Diagnostics Market Size 2021-2027 (US$ Million)
Figure 18. Japan COVID-19 Molecular Diagnostics Market Size 2021-2027 (US$ Million)
Figure 19. COVID-19 Molecular Diagnostics Market Size in China (2021-2027) (US$ Million)
Figure 20. COVID-19 Molecular Diagnostics Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 21. COVID-19 Molecular Diagnostics Market Size in India (2021-2027) (US$ Million)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
世界のリアルタイムPCR検出システム市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Real-Time PCR Detection Systems Market The global Real-Time PCR Detection Systems market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…- 世界の分子診断・NAT市場規模・現状・予測（2021年-2027年） Molecular diagnostics is the application of medical and microbiological technologies to the medical imaging science, in order to analyze biological markers present in the proteome and genome, which also includes the study of how an individual express his/her genes as proteins. The is an important di…
- 世界の分子診断・NAT市場規模・現状・予測（2021年-2027年） Molecular diagnostics is the application of medical and microbiological technologies to the medical imaging science, in order to analyze biological markers present in the proteome and genome, which also includes the study of how an individual express his/her genes as proteins. The is an important di…
- 世界のPCR＆NGSベース分子診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global PCR and NGS-Based Molecular Diagnostics Market The global PCR and NGS-Based Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis…
- 世界の分子診断市場規模・現状・予測（2021年-2027年） Molecular diagnostics market employs a range of systems, including real-time PCR systems, liquid handling systems, and DNA extraction systems, among others. Real-time PCR systems are commonly known as quantitative PCR systems. These systems monitor the amplification of the targeted DNA molecule duri…